Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

CorMedix (CRMD) Assets Average (2016 - 2025)

CorMedix's Assets Average history spans 12 years, with the latest figure at $788.5 million for Q4 2025.

  • For Q4 2025, Assets Average rose 702.82% year-over-year to $788.5 million; the TTM value through Dec 2025 reached $788.5 million, up 702.82%, while the annual FY2025 figure was $472.5 million, N/A changed from the prior year.
  • Assets Average for Q4 2025 was $788.5 million at CorMedix, up from $501.7 million in the prior quarter.
  • Across five years, Assets Average topped out at $788.5 million in Q4 2025 and bottomed at $58.1 million in Q2 2023.
  • The 5-year median for Assets Average is $72.2 million (2021), against an average of $141.4 million.
  • The largest annual shift saw Assets Average decreased 19.64% in 2022 before it skyrocketed 702.82% in 2025.
  • A 5-year view of Assets Average shows it stood at $72.2 million in 2021, then fell by 14.01% to $62.1 million in 2022, then grew by 19.62% to $74.2 million in 2023, then skyrocketed by 32.31% to $98.2 million in 2024, then surged by 702.82% to $788.5 million in 2025.
  • Per Business Quant, the three most recent readings for CRMD's Assets Average are $788.5 million (Q4 2025), $501.7 million (Q3 2025), and $201.1 million (Q2 2025).